Skip to content

Correlation between serum magnesium level and MAFLD in physical examination population

Correlation between serum magnesium level and MAFLD in physical examination population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054817
Enrollment
Unknown
Registered
2021-12-27
Start date
2021-12-29
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic fatty liver disease

Interventions

Case group:none
control group:none

Sponsors

The Fifth Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Case group: 1. People aged 18-55 for physical examination; 2. Based on pathological or imaging evidence of fatty liver; 3. One of the three conditions of overweight/obesity, type 2 diabetes or metabolic dysfunction; Control group: 1. People aged 18-55 for physical examination; 2. No abnormality of the liver based on pathology or imaging.

Exclusion criteria

Exclusion criteria: 1. Have serious chronic diseases, such as COPD, cardiovascular and cerebrovascular diseases, history of chronic kidney disease, etc.; 2. Have a history of malignant tumor; 3. Have a long-term drinking history, such as a drinking history of more than or equal to 5 years, a daily alcohol intake of more than 40g, and a long-term history of taking liver-damaging drugs; 4. Have a history of viral hepatitis, parasitic liver disease, autoimmune liver disease, hereditary liver disease, and have a clear history of liver disease caused by metabolic factors.

Design outcomes

Primary

MeasureTime frame
serum magnesium concentration;

Countries

China

Contacts

Public ContactZeng Yingjuan

The Fifth Affiliated Hospital of Sun Yat-Sen University

zyj_hx2016@163.com+86 15919153092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026